Stocktoria
Editas Medicine, Inc. EDIT
Editas Medicine, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.5M | $32.3M | $78.1M | $19.7M | $25.5M | $90.7M | $20.5M | $31.9M | $13.7M | $6.1M |
| R&D expense | $90.0M | $199.2M | $177.7M | $175.0M | $142.5M | $158.0M | $96.9M | $90.7M | $83.2M | $57.0M |
| Operating income | -$160.0M | -$251.2M | -$169.2M | -$225.9M | -$193.1M | -$134.8M | -$140.9M | -$113.7M | -$119.9M | -$97.2M |
| Income tax | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — |
| Net income | -$160.1M | -$237.1M | -$153.2M | -$220.4M | -$192.5M | -$116.0M | -$133.7M | -$110.0M | -$120.3M | -$97.2M |
| EPS (diluted) | $-1.80 | $-2.88 | $-2.02 | $-3.21 | $-2.85 | $-1.98 | $-2.68 | — | — | — |
| Operating cash flow | -$165.2M | -$210.3M | -$132.2M | -$177.3M | -$163.8M | -$179.8M | -$40.7M | -$45.7M | -$9.4M | -$50.2M |
| Free cash flow | -$165.8M | -$219.1M | -$136.9M | -$181.5M | -$171.8M | -$187.0M | -$46.8M | -$50.5M | -$11.5M | -$53.7M |
| Cash & equivalents | $146.6M | $131.5M | $123.7M | $141.5M | $203.5M | $139.7M | $238.2M | $134.8M | $146.6M | $185.3M |
| Total assets | $186.5M | $341.6M | $499.2M | $514.3M | $677.5M | $572.6M | $508.9M | $420.4M | $373.3M | $229.2M |
| Total liabilities | $159.2M | $207.3M | $150.1M | $153.6M | $123.8M | $179.0M | $246.4M | $184.2M | $165.2M | $94.6M |
| Shareholders' equity | $27.3M | $134.3M | $349.1M | $360.7M | $553.6M | $393.6M | $262.4M | $236.2M | $208.1M | $134.6M |
Growth · year-over-year · Revenue CAGR 23.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +25.4% | -58.6% | +296.3% | -22.8% | -71.8% | +341.9% | -35.7% | +132.6% | +126.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.